Todos Medical Stock News

Todos Medical Ltd announced that its majority-owned subsidiary 3CL Pharma, Ltd is reporting a case study from a patient with long COVID who was recommended Tollovid by her US physician.  Accordin

Todos Medical Ltd. (OTCQB:TOMDF) said it has signed Billy Blanks - an American fitness icon, martial artist, actor, and the creator of the Tae Boexercise program - as the first brand ambassador for t

Todos Medical Ltd. (OTCQB:TOMDF) said it has completed the acquisition of all NLC Pharma's 3CL protease biology-related assets and formed a majority-owned subsidiary called 3CL Pharma Limited.

§  Phase 2 Study NLC-V-01 closed early after interim data analysis due to positive clinical efficacy §  Primary endpoint of time to clinical improvement reached with average reduction of 2.7 days in the Tollovir group vs. the placebo group §  0% COVID-related deaths in Tollovir™ group vs. 22% COVID-related deaths in placebo group §  Lead clinical site Shaare Zedek Medical Center now permits the use of Tollovir™ in hospitalized COVID-19...

Todos Medical and its 3CL biology-focused joint venture partner NLC Pharma Limited have announced positive interim data for the Tollovir Phase 2 clinical trial for severe and critical hospitalized co

Todos Medical Ltd. (OTCQB:TOMDF) announced a data lock for the interim data analysis for the company's Tollovir Phase 2 clinical trial for the treatment of hospitalized coronavirus (COVID-19) patients

Todos Medical Ltd. (OTCQB:TOMDF) said that it will be sponsoring Pepperdine University for hosting the 22nd Annual Celebrity Flag Football Challenge on February 12, 2022, in Malibu at the university s

New York, NY, and Tel Aviv, ISRAEL, Jan. 12, 2022 (GLOBE NEWSWIRE) -- via  NewMediaWire   -- Todos Medical, Ltd. (OTCQB: TOMDF),a comprehensive medical diagnostics and related solutions company, to

Todos Medical Ltd. (OTCQB:TOMDF) chief executive officer Gerald Commissiong issued a letter to shareholders outlining the company's progress towards a Nasdaq uplisting expected in the first half of 20

NEW YORK, NY and TEL AVIV, Israel, Jan. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today a

Todos Medical Ltd has announced that its highly automated CLIA/CAP PCR and cPass neutralizing antibody coronavirus (COVID-19) testing laboratory Provista Diagnostics achieved consecutive record weekly

Todos Medical Ltd has announced that its highly automated CLIA/CAP PCR and cPass neutralizing antibody coronavirus (COVID-19) testing laboratory Provista Diagnostics achieved consecutive record weekly

Develops proprietary technology for blood-based disease testing Offers a comprehensive suite of coronavirus (COVID-19) testing solutions Developing significant programs in cancer and Alzheimer's diagn

Todos Medical Ltd announced that its coronavirus (COVID-19) testing laboratory Provista Diagnostics has struck an agreement with a physician group that boasts a presence in over 40 states. The referen

Todos Medical Ltd. (OTCQB:TOMDF) has announced the appointment of Valentino Smith as the company's new vice president of marketing.